Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Clean and efficient cooling in vaccine transportation using Rotating Magnetocaloric Effect

Project description

A revolutionary refrigerator device for vaccine transportation

Nearly half of produced vaccines are wasted due to ineffective temperature maintenance during transportation. Safety hazard restrictions of refrigerants especially during aerial transport and issues with unreliable electricity supply in certain regions require us to revisit the vaccine cold chain. The EIC-funded MAGCCINE project aims to transform the vaccine cold chain by developing an innovative magnetocaloric refrigerator. This innovation essentially utilises a rotating magnetic field to induce temperature changes that can be harnessed for cooling purposes. The project’s goal is to create a fully operational prototype for maintaining vaccines at 2-8 °C, offering a green alternative to existing solutions at reduced cost.

Objective

Every year 1.5 million lives are lost worldwide due to insufficient access to vaccination while, paradoxically, over 50% of all produced vaccines are wasted, mostly due to ineffective temperature control during storage/transportation. The major challenges of the vaccine cold chain are the evermore strict limitations imposed on their aerial transport due to the safety hazards of refrigerant gases, the high-power demand of active refrigeration devices in last-mile deliveries where the electricity supply is unreliable, and the significant carbon footprint of high global warming potential refrigerants.
The Magccine project aims to revolutionize the vaccine cold chain by developing a clean and efficient solid state magnetic refrigerator based on a novel approach: the rotating magnetocaloric effect (RMCE) – a recently (2023) patent pending technology by project partners. By reducing the amount of permanent magnets required, the RMCE is expected to enable drastic cuts in the device’s production cost, volume and weight, while enhancing efficiency without the use of any high GWP or hazardous refrigerant gases, highlighting its role as a key enabling technology for tackling vaccine cold chain challenges. Magccine´s goal is to develop and optimize a fully operational prototype for vaccine refrigeration in the 2-8 ºC temperature range, which is required by most vaccines, addressing the Generation of clean cooling and clean cold chain transportation categories of this Challenge.
To this end, this project requires top-level expertise on magnetocaloric materials, magnetic field design, thermodynamic simulations and heat pumps which are perfectly matched by the complementary expertise of the five academic institutions (U.Porto CNRS, U. Seville, U.Aveiro U.Ljubljana) and the two industrial partners (MagREEsource, Helium 3). Our endeavors will be guided by an experienced advisory board including global key leaders such as WHO, UNICEF, Cemafroid, APIRAC, IIR, Medgree, and Addvolt.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2023-PATHFINDERCHALLENGES-01

See all projects funded under this call

Coordinator

UNIVERSIDADE DO PORTO
Net EU contribution
€ 752 238,75
Address
PRACA GOMES TEIXEIRA
4099-002 Porto
Portugal
Region
Continente Norte Área Metropolitana do Porto
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 752 238,75

Participants (7)